BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3523874)

  • 1. HLA antigens on red cells. Implications for achieving low HLA antigen content in blood transfusions.
    Rivera R; Scornik JC
    Transfusion; 1986; 26(4):375-81. PubMed ID: 3523874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class I HLA molecules on human erythrocytes. Quantitation and transfusion effects.
    Everett ET; Kao KJ; Scornik JC
    Transplantation; 1987 Jul; 44(1):123-9. PubMed ID: 3603672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA antigens on peripheral red blood cells: analysis by flow cytofluorometry using monoclonal antibodies.
    de Villartay JP; Rouger P; Muller JY; Salmon C
    Tissue Antigens; 1985 Jul; 26(1):12-9. PubMed ID: 3898468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-specific transfusions. Donor-recipient HLA compatibility, recipient HLA haplotype, and antibody production.
    Radvany RM; Patel KM
    Transfusion; 1988; 28(2):137-41. PubMed ID: 3281335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of HLA antigens on red cells. Survival studies in HLA-sensitized individuals.
    Panzer S; Mueller-Eckhardt G; Salama A; Strauss BE; Kiefel V; Mueller-Eckhardt C
    Transfusion; 1984; 24(6):486-9. PubMed ID: 6542262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemolytic transfusion reactions due to HLA antibodies. A prospective study combining red-cell serology with investigations of chromium-51-labelled red-cell kinetics.
    Panzer S; Püchler K; Mayr WR; Höcker P; Graninger W; Lechner K
    Lancet; 1987 Feb; 1(8531):474-8. PubMed ID: 2881040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between murine beta 2-microglobulin and HLA class I heavy chains results in serologically detectable conformational changes of both chains.
    Ferrier P; Layet C; Caillol DH; Jordan BR; Lemonnier FA
    J Immunol; 1985 Aug; 135(2):1281-7. PubMed ID: 2409144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential analysis of monomorphic and polymorphic major histocompatibility complex antigen expression in human heart allograft biopsy specimens.
    Steinhoff G; Wonigeit K; Schäfers HJ; Haverich A
    J Heart Transplant; 1989; 8(5):360-70. PubMed ID: 2552061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of HLA (Bg) on red cells and platelets by immunoblotting with monoclonal antibodies.
    Giles CM; Botto M; King MJ
    Transfusion; 1990 Feb; 30(2):126-32. PubMed ID: 1689515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet transfusion from donors mismatched for crossreactive HLA antigens.
    Dahlke MB; Weiss KL
    Transfusion; 1984; 24(4):299-302. PubMed ID: 6464151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of HLA antigens on blood platelets and lymphocytes by means of monoclonal antibodies in an ELISA technique.
    Lansdorp PM; Oosterhof F; Astaldi GC; Zeijlemaker WP
    Tissue Antigens; 1982 Jan; 19(1):11-9. PubMed ID: 6176045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulatory role of monomorphic and polymorphic determinants of histocompatibility leukocyte antigen class I antigens in monoclonal antibody OKT3-induced T cell proliferation.
    De Felice M; Turco MC; Giarrusso PC; Corbo L; Pizzano R; Martinelli V; Ferrone S; Venuta S
    J Immunol; 1987 Oct; 139(8):2683-9. PubMed ID: 2443568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of antigens on leukocytes in banked platelet concentrates: decline in HLA-DR antigen expression and mixed lymphocyte culture stimulating capacity following storage.
    Sherman ME; Dzik WH
    Blood; 1988 Sep; 72(3):867-72. PubMed ID: 2970874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloantibody responses in multiply transfused sickle cell patients.
    Reisner EG; Kostyu DD; Phillips G; Walker C; Dawson DV
    Tissue Antigens; 1987 Oct; 30(4):161-6. PubMed ID: 3686516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in non-MHC restricted cytotoxic activities of human peripheral blood lymphocytes after transfusion with allogeneic leukocytes or platelets possessing class I and/or class II MHC molecules.
    Pócsik E; Mihalik R; Réti M; Gyódi E; Pálóczi K; Mayer K; Kassai M; Herold M; Huber C; Petrányi GG
    Immunobiology; 1990 Dec; 182(1):22-31. PubMed ID: 1983002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets do not adsorb HLA class I molecules during storage of pooled platelet concentrates.
    Zeiler T; Heim M; Dempfle A; Kretschmer V
    Transfus Med; 2006 Jun; 16(3):176-83. PubMed ID: 16764596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-HLA antibodies in nephropathic patients].
    Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
    G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HLA and transfusion: new approaches with Luminex™ technology].
    Giannoli C; Nguyen TK; Dubois V
    Transfus Clin Biol; 2011 Apr; 18(2):218-23. PubMed ID: 21397543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte antigen and antibody detection assays: tools for assessing and preventing pulmonary transfusion reactions.
    Stroncek DF; Fadeyi E; Adams S
    Transfus Med Rev; 2007 Oct; 21(4):273-86. PubMed ID: 17900489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.